Dissemin is shutting down on January 1st, 2025

Published in

Wiley Open Access, Influenza and Other Respiratory Viruses, 2(10), p. 113-121, 2016

DOI: 10.1111/irv.12359

Links

Tools

Export citation

Search in Google Scholar

Cost effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Influenza causes over than 4 000 deaths in Canada annually, the large majority of which are attributable to type A strains[1]. While vaccination is the cornerstone of prevention, antiviral drugs are the only specific medication for influenza infection. They are most effective at reducing complications when used early (within 48 h of illness onset)[2]. Management of influenza infections remains a challenge, mainly because of the difficulty in making a rapid and accurate diagnosis. Clinical diagnostic criteria lack accuracy compared with laboratory methods because influenza causes a wide spectrum of disease that is often clinically indistinguishable from other respiratory infections[3]. This article is protected by copyright. All rights reserved.